Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (DFPH) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Oncology Institute (DFPH) over the last 5 years, with Q3 2025 value amounting to 2.85.

  • Oncology Institute's Asset Utilization Ratio rose 3497.29% to 2.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 2.85, marking a year-over-year increase of 3497.29%. This contributed to the annual value of 2.06 for FY2024, which is 4958.95% up from last year.
  • As of Q3 2025, Oncology Institute's Asset Utilization Ratio stood at 2.85, which was up 3497.29% from 2.62 recorded in Q2 2025.
  • Oncology Institute's 5-year Asset Utilization Ratio high stood at 2.85 for Q3 2025, and its period low was 0.33 during Q1 2021.
  • Over the past 5 years, Oncology Institute's median Asset Utilization Ratio value was 1.26 (recorded in 2023), while the average stood at 1.44.
  • Data for Oncology Institute's Asset Utilization Ratio shows a peak YoY increase of 21226.49% (in 2022) and a maximum YoY decrease of 110.16% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Oncology Institute's Asset Utilization Ratio stood at 0.94 in 2021, then decreased by 1.1% to 0.93 in 2022, then surged by 63.82% to 1.52 in 2023, then surged by 47.43% to 2.24 in 2024, then grew by 27.51% to 2.85 in 2025.
  • Its last three reported values are 2.85 in Q3 2025, 2.62 for Q2 2025, and 2.39 during Q1 2025.